Race/Ethnicity, Spirometry Reference Equations, and Prediction of Incident Clinical Events: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study
- PMID: 34913853
- PMCID: PMC12042908
- DOI: 10.1164/rccm.202107-1612OC
Race/Ethnicity, Spirometry Reference Equations, and Prediction of Incident Clinical Events: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study
Abstract
Rationale: Normal values for FEV1 and FVC are currently calculated using cross-sectional reference equations that include terms for race/ethnicity, an approach that may reinforce disparities and is of unclear clinical benefit. Objectives: To determine whether race/ethnicity-based spirometry reference equations improve the prediction of incident chronic lower respiratory disease (CLRD) events and mortality compared with race/ethnicity-neutral equations. Methods: The MESA Lung Study, a population-based, prospective cohort study of White, Black, Hispanic, and Asian adults, performed standardized spirometry from 2004 to 2006. Predicted values for spirometry were calculated using race/ethnicity-based equations following guidelines and, alternatively, race/ethnicity-neutral equations without terms for race/ethnicity. Participants were followed for events through 2019. Measurements and Main Results: The mean age of 3,344 participants was 65 years, and self-reported race/ethnicity was 36% White, 25% Black, 23% Hispanic, and 17% Asian. There were 181 incident CLRD-related events and 547 deaths over a median of 11.6 years. There was no evidence that percentage predicted FEV1 or FVC calculated using race/ethnicity-based equations improved the prediction of CLRD-related events compared with those calculated using race/ethnicity-neutral equations (difference in C statistics for FEV1, -0.005; 95% confidence interval [CI], -0.013 to 0.003; difference in C statistic for FVC, -0.008; 95% CI, -0.016 to -0.0006). Findings were similar for mortality (difference in C statistics for FEV1, -0.002; 95% CI, -0.008 to 0.003; difference in C statistics for FVC, -0.004; 95% CI, -0.009 to 0.001). Conclusions: There was no evidence that race/ethnicity-based spirometry reference equations improved the prediction of clinical events compared with race/ethnicity-neutral equations. The inclusion of race/ethnicity in spirometry reference equations should be reconsidered.
Keywords: chronic lower respiratory disease; pulmonary function tests; race/ethnicity–based reference equations; racism; spirometry.
Figures


Comment in
-
The Vanishing Rationale for the Race Adjustment in Pulmonary Function Test Interpretation.Am J Respir Crit Care Med. 2022 Mar 15;205(6):612-614. doi: 10.1164/rccm.202112-2772ED. Am J Respir Crit Care Med. 2022. PMID: 35085469 No abstract available.
-
Race/Ethnicity and Reference Equations for Spirometry.Am J Respir Crit Care Med. 2022 Sep 15;206(6):790-792. doi: 10.1164/rccm.202201-0197LE. Am J Respir Crit Care Med. 2022. PMID: 35503241 Free PMC article. No abstract available.
-
U.S. Occupational Historical Perspective on Race and Lung Function.Am J Respir Crit Care Med. 2022 Sep 15;206(6):789-790. doi: 10.1164/rccm.202203-0565LE. Am J Respir Crit Care Med. 2022. PMID: 35503517 Free PMC article. No abstract available.
-
Reply by Elmaleh-Sachs et al. to Townsend and Cowl, and to Miller et al.Am J Respir Crit Care Med. 2022 Sep 15;206(6):792-795. doi: 10.1164/rccm.202204-0628LE. Am J Respir Crit Care Med. 2022. PMID: 35503649 Free PMC article. No abstract available.
References
-
- Gould BA. New York: Hurd & Houghton; 1869. Investigations in the military and anthropological statistics of American soldiers.
-
- Braun L. Minneapolis: University of Minnesota Press; 2014. Breathing race into the machine: the surprising career of the spirometer from plantation to genetics.
Publication types
MeSH terms
Grants and funding
- T32HP10260/HRSA/HRSA HHS/United States
- N01 HC095168/HL/NHLBI NIH HHS/United States
- F32 HL158160/HL/NHLBI NIH HHS/United States
- 75N92020D00001/HL/NHLBI NIH HHS/United States
- R01 HL077612/HL/NHLBI NIH HHS/United States
- N01 HC095167/HL/NHLBI NIH HHS/United States
- HHSN268201500003I/HL/NHLBI NIH HHS/United States
- R01 HL130506/HL/NHLBI NIH HHS/United States
- UL1 TR000040/TR/NCATS NIH HHS/United States
- N01 HC095166/HL/NHLBI NIH HHS/United States
- N01 HC095160/HL/NHLBI NIH HHS/United States
- 75N92020D00002/HL/NHLBI NIH HHS/United States
- HHSN268201500003C/HL/NHLBI NIH HHS/United States
- R01-HL093081/HB/NHLBI NIH HHS/United States
- N01 HC095161/HL/NHLBI NIH HHS/United States
- 75N92020D00005/HL/NHLBI NIH HHS/United States
- UL1 TR001079/TR/NCATS NIH HHS/United States
- N01 HC095169/HL/NHLBI NIH HHS/United States
- N01 HC095159/HL/NHLBI NIH HHS/United States
- 75N92020D00003/HL/NHLBI NIH HHS/United States
- R01 HL093081/HL/NHLBI NIH HHS/United States
- R01-HL077612/HB/NHLBI NIH HHS/United States
- UL1 TR001420/TR/NCATS NIH HHS/United States
- 75N92020D00004/HL/NHLBI NIH HHS/United States
- N01 HC095163/HL/NHLBI NIH HHS/United States
- 75N92020D00007/HL/NHLBI NIH HHS/United States
- N01 HC095162/HL/NHLBI NIH HHS/United States
- 75N92020D00006/HL/NHLBI NIH HHS/United States
- K23 HL130627/HL/NHLBI NIH HHS/United States
- N01 HC095165/HL/NHLBI NIH HHS/United States
- N01 HC095164/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical